Narrow search
Showing 1 - 10 of 313,474
Cover Image
Our right to drugs : the case for a free market
Szasz, Thomas S. - 1992
Persistent link: https://www.econbiz.de/10000857951
Cover Image
Congress and regulation : the case of the pharmaceutical industry
Brastow, Raymond T. - 1988
Persistent link: https://www.econbiz.de/10000772456
Cover Image
Drugs on the market : the impact of public policy on the retail market for prescription drugs
Cady, John F. - 1975
Persistent link: https://www.econbiz.de/10000334424
Cover Image
Hatch Waxman Act and the Indian pharmaceutical firms : an analysis
Sahay, Arvind; Saini, Gordhan Kumar - In: Foreign trade review : quarterly journal of Indian … 43 (2008) 2, pp. 3-35
Persistent link: https://www.econbiz.de/10003784821
Cover Image
Black Box Warnings and drug safety : examining the determinants and timing of FDA warning labels
Begosh, Allan; Goldsmith, John; Hass, Ed; Lutter, Randall W. - 2006
Persistent link: https://www.econbiz.de/10003407440
Cover Image
Public debate : the US food and drug administration and new drug approvals ; a safety vs. innovation paradox?
Hemphill, Thomas A. - In: Innovation: organization & management : IOM 15 (2013) 3, pp. 364-367
Persistent link: https://www.econbiz.de/10010226637
Cover Image
Market restraints in the retail drug industry
Fletcher, F. Marion - 1967
Persistent link: https://www.econbiz.de/10002193951
Cover Image
The pharmaceutical industry : access and outlook
Parvis, Ethan N. (contributor) - 2002
Persistent link: https://www.econbiz.de/10001659596
Cover Image
The economic side effects of dangerous drug announcements
Dranove, David - In: The journal of law & economics 37 (1994) 2, pp. 323-348
Persistent link: https://www.econbiz.de/10001170204
Cover Image
Do important drugs reach the market sooner?
Dranove, David - In: The Rand journal of economics 25 (1994) 3, pp. 402-423
Persistent link: https://www.econbiz.de/10001166457